Emerson Erik C. has filed 5 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 215000 shares of Apimeds Pharmaceuticals US, Inc. ($APUS) on October 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 15, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Emerson Erik C. | Chief Executive Officer | A | Stock Option (right to buy) | 215000 | $0.00 | 215,000.0000 | 12,575,983 | 9999.99% | 1.71% |
| May 16, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Emerson Erik C. | Chief Executive Officer | A | Common Stock, par value $0.01 per share | 750000 | $0.00 | 750,000.0000 | 7,903,850 | 9999.99% | 9.49% |
| May 16, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Emerson Erik C. | Chief Executive Officer | A | Stock option (right to buy) | 347279 | $0.00 | 347,279.0000 | 7,903,850 | 9999.99% | 4.39% |
| Jan. 16, 2024 | Odyssey Health, Inc. | $ODYY | Emerson Erik C. | Other | A | Stock Option (Right to Buy) | 37500 | $0.09 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | Odyssey Health, Inc. | $ODYY | Emerson Erik C. | Other | A | Stock Option (Right to Buy) | 200000 | $0.10 | 200,000.0000 | 0 | 9999.99% | 0.00% |